Featured Studies

Researchers at the National Institutes of Health's (NIH) Clinical Center are looking for adult volunteers for a study on whether an aerobic exercise program benefits survivors of COVID-19. (En español)

Investigadores del Centro Clínico de los Institutos Nacionales de la Salud (NIH, por sus siglas en inglés) buscan voluntarios para un estudio que investiga si un programa de ejercicios aeróbicos puede beneficiar a los sobrevivientes de COVID-19.

Do you have Parkinson's disease? Doctors at the National Institute of Neurological Disorders and Stroke (NINDS) are conducting a research study on people with Movement Disorders. They are currently recruiting participants with Parkinson's disease. The purpose is to learn more about the disease and identify genetic changes and other indicators of the condition that may allow earlier diagnosis.There is no cost for study-related tests or procedures. Travel assistance may be provided.

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is conducting a pilot intervention study for patients diagnosed with idiopathic membranous nephropathy. The purpose of this study is to evaluate the safety and effectiveness of Rituximab plus Cyclosporine in the treatment of membranous nephropathy. There is no cost for study-related medications or tests received.

The National Institute of Neurological Disorders and Stroke at the National Institutes of Health Clinical Center is looking for individuals with severe epilepsy or individuals who have experienced persistent seizure activity that cannot be controlled with medication, to participate in this research study. The goal of this research study is to provide surgical treatment to control these types of seizures. Participation requires an inpatient stay of up to 4 weeks, plus 3 outpatient visits within 2 years after surgery.

Researchers at the National Institutes of Health (NIH) Clinical Center are testing if spironolactone can be used to treat PAH. Spironolactone is a medication that can help with fluid retention, however it may also be beneficial to adults with PAH by controlling inflammation and improving blood vessel function in the lungs.

Doctors at the National Institutes of Health (NIH) are enrolling people with LAM into a research study. LAM is a rare progressive lung disease that usually strikes women during their childbearing years, between the onset of puberty and menopause. One possible treatment to improve breathing in patients with LAM is inhaled albuterol. Albuterol can be given using a hand held inhaler or with a nebulizer. The study wants to compare these methods to see which method improves lung function in patients with LAM.

If you or someone you know is drinking too much, the National Institutes of Health (NIH) may be able to help. We conduct studies on how alcohol affects the body and are looking for new ways to treat alcohol problems. If you qualify, you can receive alcoholism treatment at no-cost while you participate in our research.